Evaluation of serum HMGB-1 and serum P-glycoprotein levels in epileptic patients: Associations with clinical features, seizure patterns, and drug resistance


ALTINALAN E., Gursoy G., Nazli E., YİĞİT P., Onder T., ÇETİNKAYA Y., ...Daha Fazla

Acta Pharmaceutica Sciencia, cilt.63, sa.4, ss.789-804, 2025 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 4
  • Basım Tarihi: 2025
  • Doi Numarası: 10.23893/1307-2080.aps6348
  • Dergi Adı: Acta Pharmaceutica Sciencia
  • Derginin Tarandığı İndeksler: Scopus, EMBASE
  • Sayfa Sayıları: ss.789-804
  • Anahtar Kelimeler: drug resistance, epilepsy, HMGB-1, P-glycoprotein, serum
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

This study aimed to evaluate the association of serum HMGB-1 and serum P-gp levels with clinical characteristics, seizure patterns, and drug resistance in patients with epilepsy. Patients were divided into monotherapy (n=40) and polytherapy (n=40) groups, and their serum HMGB-1 and serum P-gp levels were analysed using the ELISA technique. In the multinomial logistic regression model, serum P-gp levels were significantly higher in the polytherapy group compared to the healthy control group (p=0.021). Additionally, to the best of our knowledge, this is the first study to analyse the correlation between serum HMGB-1 and serum P-gp levels. In this study, a moderate positive correlation was found between serum HMGB-1 and serum P-gp levels in the monotherapy group of epilepsy patients.